Leona Health | $14,000,000 | (Dec 18, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
Codoxo | $35,000,000 | (Dec 18, 2025)
Certified by Founder
Lodge
Loyal / Cellular Longevity
start up
United States
- San Francisco, CA
- 22/03/2024
- Series B
- $45,000,000
Loyal is part of Cellular Longevity, a company working to develop the first drugs explicitly intended to extend healthspan and lifespan — first in dogs, and then in humans, too.
By quantifying and controlling the mechanisms of aging, we hope to delay the onset and reduce the severity of age-related diseases, which means more, healthier years for both species.
At Loyal, our first products to market are focused on longevity and healthspan in dogs. Join us in our mission to help dogs everywhere.
- Industry Biotechnology Research
- Website https://loyalfordogs.com/
- LinkedIn https://www.linkedin.com/company/loyalfordogs/
Related People
Celine HaliouaFounder
United States -
San Francisco, California
Interested in: the biology of aging, the impact of healthcare inequality, economics of novel therapeutics, early-stage biotech venture capital. www.celinehh.com
Drive Health | $15,000,000 | (Dec 18, 2025)
DataLane | $22,500,000 | (Dec 18, 2025)
Addition Therapeutics | $100,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)
Scylos | $3,000,000 | (Dec 18, 2025)
Last Energy | $100,000,000 | (Dec 18, 2025)
Limenet | $8,217,860 | (Dec 18, 2025)
Navier AI | $6,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)